The Lancet Neurology
The Lancet Neurology serves as a vital platform for influential figures in medicine, government, and health systems to shape clinical practices, discuss global health policies, and promote positive changes around the world. Recognized as a leading source in clinical neurology, The Lancet Neurology offers vital original research, expert reviews, insightful commentary, and timely news that shed light on significant medical advancements across various areas of clinical neurology. Each article in The Lancet Neurology undergoes rigorous editing and peer review to ensure its scientific quality and clinical importance. Original research is prioritized for publication, typically appearing within 8 weeks of submission and available online at thelancet.com before being included in the print edition. Articles from the journal often gain attention in major print, online, and broadcast media outlets.
Outlet metrics
Global
#19634
United States
#13888
Health/Health
#300
Articles
-
1 week ago |
thelancet.com | Dan Stein |Michael Carter |John Booth
KeywordsCritical & intensive & emergency carePaediatric intensive careDigital healthArtificial intelligenceEvidence before this studyWhilst there have been many studies predicting clinical deterioration in adult intensive care units, there are only a small number predicting outcomes in Paediatric Intensive Care Units (PICUs). Of these, most focus on late severe outcomes such as cardiovascular collapse or cardiac arrest or rare irreversible outcomes such as death.
-
1 week ago |
thelancet.com | Priya Venkatesan
Climate change and global warming driven by air pollution and carbon emissions are contributing to worsening respiratory health and increasing numbers of asthma-related emergencies and deaths . Australia is particularly susceptible to the effects of climate change, with longer bushfire seasons and extreme weather events associated with sharp increases in asthma-related hospital admissions.
-
2 weeks ago |
thelancet.com | Paul Adepoju
Despite being declared a Public Health Emergency of International Concern 10 months ago, the mpox outbreak is not over. And in places like Sierra Leone, it is spiralling. Paul Adepoju reports.
-
2 weeks ago |
thelancet.com | Priya Venkatesan
Three trials of treatments for idiopathic or progressive pulmonary fibrosis (PPF) were presented. The ELEVATE study compared deupirfenidone, a deuterated form of pirfenidone, with placebo and pirfenidone in 257 patients with idiopathic pulmonary fibrosis (IPF; median age 72 years). 65 patients were assigned deupirfenidone 550 mg, 65 were assigned deupirfenidone 825 mg, 61 were assigned pirfenidone 801 mg, and 65 were assigned placebo, all doses were given three times per day.
-
2 weeks ago |
thelancet.com | Tezer Kutluk
References1. Alessy, SA ∙ Al-Zahrani, A ∙ Alhomoud, S ∙ et al. Towards a comprehensive cancer control policy in Saudi ArabiaLancet Oncol. 2025;2. Al-Thani, MBH ∙ Subramanian, M ∙ Halabi, N ∙ et al. Qatar national cancer care and research: pioneering strategies for global health excellenceLancet Oncol. 2025;3. Abdel-Razeq, H ∙ Rayyan, Y ∙ Al-rabi, K ∙ et al. Transforming cancer care in Jordan: a 10-year comprehensive patient-centred strategy guided by local expertsLancet Oncol. 2025;5.
The Lancet Neurology journalists
Contact details
Address
123 Example Street
City, Country 12345
Phone
+1 (555) 123-4567
Email Patterns
Try JournoFinder For Free
Search and contact over 1M+ journalist profiles, browse 100M+ articles, and unlock powerful PR tools.
Start Your 7-Day Free Trial →